POLYPEPTID UND VERWENDUNG DAVON

European patent · EP4349871 · In force

Register entry

Publication number
EP4349871
Application number
EP23828948
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 23, 2023
Published
Apr 10, 2024
Granted
Jul 1, 2026
Protection ends at the latest
Feb 22, 2043
Next annual fee due
Feb 28, 2027
IPC classes
C07K 19/00 (2006.01)
C07K 14/78 (2006.01)
C12N 15/70 (2006.01)
C12N 15/12 (2006.01)
C12N 1/21 (2006.01)
C12P 21/02 (2006.01)
A61L 27/24 (2006.01)
A61L 27/50 (2006.01)
A61L 27/52 (2006.01)
Priority
CN 202210761804 29.06.2022
PCT application
PCT/CN2023/077950 23.02.2023
PCT publication
WO2024/001242 04.01.2024
Filing language
Chinese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 8, 2026

    Agent entered

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 08.07.2026

  2. Jul 1, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.07.2026

Parties

Inventor

YANG, Xia

Taiyuan, Shanxi 030032, CN

HE, Zhenrui

Taiyuan, Shanxi 030032, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.